Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A case of SOD1 deficiency: implications for clinical trials

Journal article

Farrimond L. and Talbot K., (2022), BRAIN

Genetic testing in motor neurone disease.

Journal article

Dharmadasa T. et al, (2022), Pract Neurol

Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers

Journal article

Vahsen BF. et al, (2021), Nature Reviews Neurology

Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy

Journal article

Winkelsas AM. et al, (2021), Molecular Therapy - Nucleic Acids, 23, 731 - 742

The Role of Mitochondrial Dysfunction and ER Stress in TDP-43 and C9ORF72 ALS.

Journal article

Dafinca R. et al, (2021), Front Cell Neurosci, 15

Improving clinical trial outcomes in amyotrophic lateral sclerosis.

Journal article

Kiernan MC. et al, (2020), Nat Rev Neurol

Detection and quantification of novel C-terminal TDP-43 fragments in ALS-TDP

Journal article

FENEBERG E. et al, (2020), Brain Pathology

Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia.

Journal article

Prudencio M. et al, (2020), J Clin Invest, 130, 6080 - 6092

Leukoencephalopathy with calcifications and cysts: Genetic and phenotypic spectrum.

Journal article

Crow YJ. et al, (2020), Am J Med Genet A

Motor Neuron Disease Register for England, Wales and Northern Ireland-an analysis of incidence in England.

Journal article

Opie-Martin S. et al, (2020), Amyotroph Lateral Scler Frontotemporal Degener, 1 - 8

Load More